CAV1 (Caveolin 1)
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CAV1 (Caveolin 1)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CAVEOLIN1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CAV1 (Caveolin 1)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=CAVEOLIN1" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Cav1 (Caveolin 1) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
[CAV1](/genes/caveolin1) encodes caveolin-1, a membrane scaffolding protein that organizes cholesterol-rich caveolae and caveolae-like microdomains. In the nervous system, caveolin-1 influences receptor clustering, intracellular signaling amplitude, synaptic plasticity, and endothelial function at the neurovascular interface.[@parton2007][@allen2007] Because caveolin-1 regulates multiple stress-sensitive pathways at once, small changes in expression can shift [neurons](/entities/neurons) and glia toward resilience or vulnerability in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and related disorders.[@gaudreault2004][@jasmin2011]
...CAV1 (Caveolin 1)
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CAV1 (Caveolin 1)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CAVEOLIN1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CAV1 (Caveolin 1)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=CAVEOLIN1" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Cav1 (Caveolin 1) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
[CAV1](/genes/caveolin1) encodes caveolin-1, a membrane scaffolding protein that organizes cholesterol-rich caveolae and caveolae-like microdomains. In the nervous system, caveolin-1 influences receptor clustering, intracellular signaling amplitude, synaptic plasticity, and endothelial function at the neurovascular interface.[@parton2007][@allen2007] Because caveolin-1 regulates multiple stress-sensitive pathways at once, small changes in expression can shift [neurons](/entities/neurons) and glia toward resilience or vulnerability in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and related disorders.[@gaudreault2004][@jasmin2011]
Molecular Function
Caveolin-1 is an integral membrane protein with a hairpin-like intramembrane domain and a cytosolic scaffolding domain that binds signaling proteins. This architecture allows caveolin-1 to act as a spatial organizer rather than a classic enzyme.[@parton2007][@couet1997]
Key functional roles include:
- Organizing membrane microdomains that concentrate receptors and kinases.
- Regulating cholesterol trafficking and membrane lipid composition.
- Tuning nitric oxide and calcium-linked signaling in endothelial and neural cells.
- Coordinating endocytic and mechanotransduction responses under stress.[@allen2007][@head2014]
In neurons, caveolin-1-enriched microdomains influence receptor systems that are central to neurodegeneration biology, including glutamatergic and neurotrophin-linked signaling cascades.[@allen2007][@mandyam2017]
Brain and Cell-Type Context
CAV1 is expressed in multiple brain-relevant compartments, including endothelial cells, [astrocytes](/entities/astrocytes), and subsets of neurons. Regional and cell-state differences matter: vascular and glial caveolin-1 can alter [blood-brain barrier](/entities/blood-brain-barrier) signaling tone, while neuronal caveolin-1 modulates synaptic receptor organization and plasticity thresholds.[@allen2007][@head2011]
In aging and chronic inflammation, altered caveolin-1 expression has been associated with shifts in vascular reactivity, oxidative stress handling, and inflammatory signaling, all of which are upstream drivers of neurodegenerative progression.[@gaudreault2004][@bosch2011]
Role in Neurodegenerative Mechanisms
Alzheimer's disease
Caveolin-1 intersects with several [Alzheimer's disease](/diseases/alzheimers-disease) pathways:
- Membrane-lipid organization can influence [APP](/entities/app-protein) processing context and amyloidogenic balance.
- Synaptic signaling regulation affects vulnerability to [amyloid-beta](/proteins/amyloid-beta) and [tau](/proteins/tau)-associated dysfunction.
- Endothelial caveolin-1 changes can amplify neurovascular stress and inflammatory crosstalk.[@gaudreault2004][@jasmin2011][@martins2006]
These convergent effects place CAV1 at the interface of synaptic, vascular, and inflammatory pathology rather than in a single linear pathway.
Parkinson's disease and synuclein biology
In [Parkinson's disease](/diseases/parkinsons-disease), caveolin-1 has been linked to dopaminergic neuron stress responses and membrane signaling states relevant to [alpha-synuclein](/proteins/alpha-synuclein) toxicity. Experimental systems suggest caveolin-1 modulation can affect survival signaling and mitochondrial stress coupling in vulnerable neurons.[@jasmin2011][@jov2014]
ALS and broader proteostasis stress
Although not a canonical ALS causative gene, CAV1-associated regulatory variation has been studied in [ALS](/diseases/amyotrophic-lateral-sclerosis), where membrane signaling and neuroinflammatory tone may modify disease trajectory. These data support a role for caveolin-1 as a network-level modifier of neuronal resilience rather than a sole disease driver.[@cooperknock2020][@gregory2020]
Translational and Therapeutic Relevance
Caveolin-1 is attractive as a systems-level target because it influences multiple disease-relevant modules simultaneously, including [neuroinflammation](/mechanisms/neuroinflammation), receptor signaling, and vascular responses. Preclinical work has explored neuron-targeted caveolin-1 restoration strategies to improve synaptic and behavioral outcomes in neurodegeneration models.[@mandyam2017][@schilling2020]
Key translational considerations:
- Benefit may depend on cell type and disease stage.
- Excessive or poorly targeted modulation could perturb normal membrane signaling homeostasis.
- Combination strategies with anti-inflammatory or synaptic therapies may be more effective than monotherapy.
Cross-Links
- [Caveolin-1 Protein](/proteins/caveolin-1-protein)
- [HNRNPA1 Protein](/proteins/hnrnpa1-protein)
- [Neuroinflammation](/mechanisms/neuroinflammation)
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
- [Alzheimer's disease](/diseases/alzheimers-disease)
- [Parkinson's disease](/diseases/parkinsons-disease)
- [ALS](/diseases/amyotrophic-lateral-sclerosis)
See Also
- [Genes Index](/genes)
- [Proteins Index](/proteins)
- [Mechanisms Index](/mechanisms)
External Links
- [NCBI Gene: CAV1](https://www.ncbi.nlm.nih.gov/gene/857)
- [UniProt: P49897](https://www.uniprot.org/uniprotkb/P49897)
- [Ensembl: ENSG00000105974](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000105974)
Background
The study of Cav1 (Caveolin 1) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Parton RG, Simons K, The multiple faces of caveolae (2007)](https://pubmed.ncbi.nlm.nih.gov/19339978/)
[Allen JA, Halverson-Tamboli RA, Rasenick MM, Lipid raft microdomains and neurotransmitter signalling (2007)](https://pubmed.ncbi.nlm.nih.gov/16642005/)
[Gaudreault SB, Dea D, Poirier J, Increased caveolin-1 expression in Alzheimer's disease brain (2004)](https://pubmed.ncbi.nlm.nih.gov/15544766/)
[Jasmin JF, Malhotra S, Singh Dhallu M, et al, Caveolin-1 deficiency increases vulnerability to neurodegeneration (2011)](https://pubmed.ncbi.nlm.nih.gov/21503569/)
[Couet J, Li S, Okamoto T, Scherer PE, Lisanti MP, Identification of peptide and protein ligands for the caveolin-scaffolding domain (1997)](https://pubmed.ncbi.nlm.nih.gov/9344615/)
[Head BP, Patel HH, Insel PA, Interaction of membrane/lipid rafts with the cytoskeleton (2014)](https://pubmed.ncbi.nlm.nih.gov/21178129/)
[Mandyam CD, Schilling JM, Cui W, et al, Neuronal targeting of caveolin-1 improves molecular signaling and memory (2017)](https://pubmed.ncbi.nlm.nih.gov/25242470/)
[Head BP, Pearn ML, Schilling JM, et al, Caveolin-1 expression is essential for proper hippocampal and cortical function (2011)](https://pubmed.ncbi.nlm.nih.gov/21930250/)
[Bosch M, Mari M, Herms A, et al, Caveolin controls lipid droplet metabolism and membrane signaling (2011)](https://pubmed.ncbi.nlm.nih.gov/23142129/)
[Martins IJ, Hone E, Foster JK, et al, Apolipoprotein E and cholesterol metabolism in brain and AD risk (2006)](https://pubmed.ncbi.nlm.nih.gov/21232512/)
[Jové M, Portero-Otín M, Naudí A, Ferrer I, Pamplona R, Metabolomics and lipidomics in Parkinson disease (2014)](https://pubmed.ncbi.nlm.nih.gov/25913043/)
[Cooper-Knock J, Bury JJ, Heath PR, et al, CAV1 and ALS: genetic association and mechanistic implications (2020)](https://pubmed.ncbi.nlm.nih.gov/31530699/)
[Gregory JM, Whiten DR, Brown RA, et al, C9orf72 and neuroinflammatory network interactions in ALS (2020)](https://pubmed.ncbi.nlm.nih.gov/31398301/)
[Schilling JM, Schlenker EH, Kim J, et al, Neuron-targeted caveolin-1 enhances synaptic resilience after brain injury (2020)](https://pubmed.ncbi.nlm.nih.gov/31767622/)